Current Status of the Implication of the Clinical Pattern in Hemodialysis Prescription in Regular Hemodialysis Patients in Giza Governerate Sector (E)

Abstract

E nd-stage renal disease (ESRD) is one of the main health problems in Egypt. Currently, hemodialysis represents the main mode for treatment of chronic kidney disease stage 5 (CKD5), previously called ESRD or chronic renal failure. Although hemodialysis is often used for treatment of ESRD, no practice guidelines are available in Egypt. Healthcare facilities are seeking nowadays to develop practice guidelines for the sake of improving healthcare services. In the healthcare sector in Egypt, trials for establishing guidelines have been lead by the MOH. This work is a part of a project aiming at assessment of the current status of dialysis patients in Egypt using a questionnaire. This project is modulated by the Nephrology department, Ain Shams University. Our study sample consisted of 286 clinically stable ESRD patients on regular HD. Patients were collected from 8 dialysis centres from Giza Governorate sector (E) which included (El Haram, Manshyet Elbakary,Tersa,Kerdasa, Bany Magdowl &Kafr Ghataty).In all patients, we recorded full history and clinical examination stressing on etiology of renal disease and associated complications. Full review of all medical records over the 6 months period of the study,and details of H D prescription were registered. Most patients (98.3%) were receiving 3 HD sessions per week, but still 1.7% received 2 sessions per week. The mean age of our dialysis patients was 48.899 ± 12.042 years, ranging from 14 – 80 years, 63.3% of them were males and were under dialysis for a mean period of 3.926± 2.578 years. Among causes of ESRD in the study population, HTN represented 46.5%, DM 25.2% and in 19.3% of patients, the cause was unknown. These results agree with those of most studies where HTN and DM were the main causes of renal failure. Different comorbidities in the study population were HTN present in 70.3% of patients, DM in 26.6%, cardio vascular disease in 4.9%, ischemic heart disease in 5.2 %, Chronic arthropathy in 1.4 %,Chronic liver disease in 1.0% and peripheral vascular disease in 0.3 % of patients.